IN8BIO, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
IN8BIO, INC. (INAB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 18.80 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 18.80M shares, a 399.42% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 18.87M shares, a 447.49% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 13.38M shares, a 270.13% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 3.76M shares, a 8.73% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 9.97M shares, a 191.59% increase from fiscal 2020.
- IN8BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.42M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 18.80M shares 10-Q · filed 2022-05-12 | 18.83M shares derived: average of 2 quarters · filed 2022-05-12 | 17.01M shares derived: average of 3 quarters · filed 2022-05-12 | 13.70M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 18.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 16.12M shares derived: average of 2 quarters · filed 2022-03-17 | 12.00M shares derived: average of 3 quarters · filed 2022-03-17 | 9.97M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 13.38M shares 10-Q · filed 2021-11-10 | 8.57M shares derived: average of 2 quarters · filed 2021-11-10 | 7.00M shares 10-Q · filed 2021-11-10 | 6.09M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | 3.76M shares 10-Q · filed 2021-09-10 | 3.76M shares 10-Q · filed 2021-09-10 | 3.66M shares derived: average of 3 quarters · filed 2022-05-12 | 3.65M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | 3.76M shares 10-Q · filed 2022-05-12 | 3.61M shares derived: average of 2 quarters · filed 2022-05-12 | 3.61M shares derived: average of 3 quarters · filed 2022-05-12 | 3.57M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 3.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 3.53M shares derived: average of 2 quarters · filed 2022-03-17 | 3.51M shares derived: average of 3 quarters · filed 2022-03-17 | 3.42M shares 10-K · filed 2022-03-17 |
| 2020-09-30 | 3.61M shares 10-Q · filed 2021-11-10 | 3.54M shares derived: average of 2 quarters · filed 2021-11-10 | 3.41M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 3.46M shares 10-Q · filed 2021-09-10 | 3.38M shares 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |